Mount Vernon Associates Inc. MD Purchases 250 Shares of GE HealthCare Technologies Inc. $GEHC

Mount Vernon Associates Inc. MD increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,971 shares of the company’s stock after buying an additional 250 shares during the period. GE HealthCare Technologies accounts for 1.0% of Mount Vernon Associates Inc. MD’s holdings, making the stock its 27th biggest holding. Mount Vernon Associates Inc. MD’s holdings in GE HealthCare Technologies were worth $1,331,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of GEHC. JPMorgan Chase & Co. raised its stake in GE HealthCare Technologies by 49.9% during the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after buying an additional 1,711,963 shares during the last quarter. Nuveen LLC bought a new position in GE HealthCare Technologies during the first quarter worth $77,058,000. Eminence Capital LP raised its stake in GE HealthCare Technologies by 38.7% during the first quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock worth $146,822,000 after buying an additional 507,101 shares during the last quarter. Homestead Advisers Corp raised its stake in GE HealthCare Technologies by 92.7% during the first quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock worth $79,790,000 after buying an additional 475,500 shares during the last quarter. Finally, Canada Pension Plan Investment Board raised its stake in GE HealthCare Technologies by 15.2% during the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after buying an additional 409,636 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 0.3%

GEHC opened at $76.56 on Friday. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The stock has a market cap of $34.95 billion, a price-to-earnings ratio of 15.69, a PEG ratio of 2.93 and a beta of 1.13. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company’s 50-day moving average price is $74.25 and its two-hundred day moving average price is $72.54.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. The firm had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the company earned $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s payout ratio is presently 2.87%.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on GEHC shares. Wall Street Zen downgraded shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Morgan Stanley set a $74.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. Citigroup lifted their price target on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a “buy” rating in a research note on Thursday, July 31st. Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Finally, BTIG Research reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Seven analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $86.89.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.